Attorney
CurrentRepresented a NASDAQ-listed biotechnology company in connection with an “at the market” public offering of up to $25 million of its common stockRepresented a private survey services company in the sale of its outstanding capital stock to a NYSE-listed engineering and applied technology company pursuant to a $230 million stock purchase agreementRepresent public companies in their compliance and reporting obligations under the Securities Act of 1933 and Securities Exchange Act of 1934Advise clients in public and private debt and equity offeringsAdvise clients on business entity formation, statutory conversions and state corporation laws